MoneyWorks4Me

The Total revenue for the quarter ended September 2023 of  Rs. 323.94 millions grew by 139.16% from Rs. 135.45 millions.Net Profit for the quarter ended September 2023 zoomed to 2769.50% from Rs. 2.00 millions to Rs. 57.39  millions.Operating profit for the quarter ended September 2023 rose to 62.68 millions as compared to 6.37 millions of corresponding quarter ended September 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 323.94 135.45 139.16 578.24 359.65 60.78 924.36 1122.66 -17.66
Other Income 29.53 63.75 -53.68 73.92 79.89 -7.47 99.27 107.94 -8.03
PBIDT 62.68 6.37 883.99 95.59 36.67 160.68 174.85 214.80 -18.60
Interest 0.36 0.81 -55.56 0.53 1.14 -53.51 2.23 2.43 -8.23
PBDT 62.32 5.56 1020.86 95.34 35.53 168.34 172.62 212.37 -18.72
Depreciation 4.93 3.56 38.48 7.69 6.93 10.97 13.28 16.57 -19.86
PBT 57.39 2.00 2769.50 87.65 28.60 206.47 159.34 195.80 -18.62
TAX 0.00 0.00 0.00 0.00 0.00 0.00 33.08 54.54 -39.35
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -2.88 23.55 -112.23
PAT 57.39 2.00 2769.50 87.65 28.60 206.47 126.26 141.26 -10.62
Equity 210.41 210.41 0.00 210.41 210.41 0.00 210.41 210.41 0.00
PBIDTM(%) 19.35 4.70 311.44 16.53 10.20 62.13 18.92 19.13 -1.14
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..